A multicenter clinical study protocol for treatment of internal hemorrhoids with Lauromacrogol injection based on LrDRf classification

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100050148

Enrollment

Unknown

Registered

2021-08-18

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Internal hemorrhoids

Interventions

Group 1:Treatment with polycinnamyl alcohol injection (Stock Solution)

Group 2:Treatment with polycinnamyl alcohol injection (Foam)

Group 3:Evisceration

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old; 2. The indications for endoscopic treatment of internal hemorrhoids classified according to lrdrf are: LR d0.3-2, rf0-2, requiring elective or emergency treatment; 3. Patients can follow the follow-up plan; Be able to objectively describe symptoms and take the initiative to complete the scale; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with acute thrombotic external hemorrhoids; 2. Patients with intractable constipation, anal fissure, anal fistula and pelvic tumor; 3. Patients with serious cardiovascular and cerebrovascular diseases and blood system diseases; 4. Pregnant and lactating women; 5. Patients considered unsuitable by the researchers.

Design outcomes

Primary

Measure	Time frame
The operation time, blood loss during operation and hospitalization time were compared between the two groups;	—

Countries

China

Contacts

Public ContactEnqiang Linghu

PLA General Hospital

linghuenqiang@vip.sina.com+86 13501233558

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026